©The Author(s) 2025.
World J Hepatol. Dec 27, 2025; 17(12): 111418
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.111418
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.111418
Table 4 Association between hepatic enhancement and Functional Liver Imaging Score in the whole cohort and subgroups (no prior hepatocellular carcinoma, viral etiology, alcoholic etiology)
| Region | F (ANOVA) | P value | Partial η² | Linear trend F | Linear trend P | Deviation F | Deviation P | Levene’s P |
| Full cohort (n = 100) | ||||||||
| Segment VI | 38.448 | < 0.001 | 0.672 | 190.171 | < 0.001 | 0.518 | 0.723 | 0.062 |
| Segment VIII | 18.960 | < 0.001 | 0.502 | 91.378 | < 0.001 | 0.855 | 0.494 | 0.246 |
| Caudate lobe | 24.369 | < 0.001 | 0.565 | 120.883 | < 0.001 | 0.240 | 0.915 | 0.340 |
| Segment III | 19.393 | < 0.001 | 0.508 | 95.767 | < 0.001 | 0.299 | 0.878 | 0.157 |
| Global HE | 28.060 | < 0.001 | 0.599 | 138.949 | < 0.001 | 0.337 | 0.852 | 0.072 |
| Non-HCC subgroup (n = 80) | ||||||||
| Segment VI | 36.974 | < 0.001 | 0.714 | 179.371 | < 0.001 | 1.375 | 0.251 | 0.086 |
| Segment VIII | 16.262 | < 0.001 | 0.524 | 77.487 | < 0.001 | 0.956 | 0.437 | 0.457 |
| Caudate lobe | 23.305 | < 0.001 | 0.612 | 114.939 | < 0.001 | 0.396 | 0.811 | 0.429 |
| Segment III | 17.696 | < 0.001 | 0.545 | 85.235 | < 0.001 | 0.811 | 0.522 | 0.174 |
| Global HE | 26.237 | < 0.001 | 0.639 | 128.016 | < 0.001 | 0.792 | 0.534 | 0.125 |
| Viral subgroup (n = 53) | ||||||||
| Segment VI | 15.968 | < 0.001 | 0.571 | 61.566 | < 0.001 | 0.769 | 0.517 | 0.017 |
| Segment VIII | 6.230 | < 0.001 | 0.342 | 22.909 | < 0.001 | 0.671 | 0.574 | 0.547 |
| Caudate lobe | 11.256 | < 0.001 | 0.484 | 43.029 | < 0.001 | 0.665 | 0.578 | 0.061 |
| Segment III | 8.940 | < 0.001 | 0.426 | 34.033 | < 0.001 | 0.576 | 0.634 | 0.152 |
| Global HE | 11.244 | < 0.001 | 0.484 | 43.239 | < 0.001 | 0.579 | 0.632 | 0.035 |
| Alcoholic subgroup (n = 41) | ||||||||
| Segment VI | 22.325 | < 0.001 | 0.761 | 103.808 | < 0.001 | 1.955 | 0.123 | 0.751 |
| Segment VIII | 9.116 | < 0.001 | 0.566 | 41.884 | < 0.001 | 0.925 | 0.461 | 0.636 |
| Caudate lobe | 7.551 | < 0.001 | 0.519 | 36.680 | < 0.001 | 0.269 | 0.896 | 0.849 |
| Segment III | 8.439 | < 0.001 | 0.566 | 38.439 | < 0.001 | 0.938 | 0.453 | 0.174 |
| Global HE | 12.871 | < 0.001 | 0.648 | 60.830 | < 0.001 | 0.881 | 0.485 | 0.803 |
- Citation: Stanciu BI, Iojiban M, Morariu-Barb A, Caraiani C, Procopet B, Stefanescu H, Lupsor-Platon M. Hepatic enhancement and signal intensity analysis on magnetic resonance imaging as prognostic biomarkers in advanced chronic liver disease. World J Hepatol 2025; 17(12): 111418
- URL: https://www.wjgnet.com/1948-5182/full/v17/i12/111418.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i12.111418